Drug-induced secondary haemophagocytic lymphohistiocytosis in hairy cell leukaemia.
J R Coll Physicians Edinb
; 54(1): 29-33, 2024 03.
Article
en En
| MEDLINE
| ID: mdl-38160201
ABSTRACT
Haemophagocytic lymphohistiocytosis (HLH) is a rare, aggressive, excess immune activation syndrome. Diagnosis can be challenging due to its several clinical mimics including sepsis. There are multiple aetiologies of HLH; in adults, it is most commonly triggered by infection, malignancy, drugs and autoimmune processes. Failure to rapidly diagnose and treat this condition can be fatal. The management of HLH includes identifying and removing the trigger, supportive management and immunosuppression. Identifying the trigger is essential to inform the most appropriate type of immunosuppression. Here, we report a case of likely drug-induced HLH in a patient recently treated for hairy cell leukaemia. The culprit drug was thought to be co-trimoxazole and this case report highlights a very rare complication of this commonly used drug. We discuss our management approach with steroid monotherapy and withdrawal of co-trimoxazole.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Leucemia de Células Pilosas
/
Sepsis
/
Linfohistiocitosis Hemofagocítica
/
Neoplasias
Límite:
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J R Coll Physicians Edinb
Asunto de la revista:
EDUCACAO
/
HISTORIA DA MEDICINA
/
MEDICINA
Año:
2024
Tipo del documento:
Article
País de afiliación:
Reino Unido
Pais de publicación:
Reino Unido